{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:36:28Z","timestamp":1791941788253,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"vor","delay-in-days":5294,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1046\/j.1469-0691.2000.00083.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T12:22:15Z","timestamp":1047385335000},"page":"389-392","source":"Crossref","is-referenced-by-count":13,"title":["Hyperglycemia associated with protease inhibitors in HIV-1-infected patients"],"prefix":"10.1016","volume":"6","author":[{"given":"J.","family":"G\u00f3mez-Vera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Jim\u00e9nez-Mej\u0131\u00b4as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2000.00083.x_bib1","series-title":"FDA Public Health Advisory: Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV).","author":"Murray","year":"1997"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib2","first-page":"379","article-title":"FDA Public Health Advisory in protease inhibitors for HIV treatment","volume":"278","author":"Nightindale","year":"1997","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib3","series-title":"37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario.","first-page":"9","article-title":"Hyperglycemia associated with protease inhibitors in HIV-infected patients [abstract LB-8]","author":"Dever","year":"1997"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib4","series-title":"5th Conference on Retrovirus and Opportunistic Infections","first-page":"157","article-title":"Diabetes and hyperglycemia in patients receiving protease inhibitors [abstract 415]","author":"Keruly","year":"1998"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dub\u00e3\u00a9","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib7","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients","volume":"12","author":"Wali","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib8","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"188","article-title":"Frequency of lipodystrophy and factors associated with glucose\/lipid abnormalities in a cohort of 650 patients treated by protease inhibitors [abstract 642]","author":"Gharakhanian","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib9","series-title":"5th Conference on Retrovirus and Opportunistic Infections","first-page":"157","article-title":"Diabetes and use of protease inhibitors [abstract 416]","author":"Dong","year":"1998"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib10","first-page":"599","article-title":"Hipertrigliceridemia y diabetes mellitus asociadas al uso de inhibidores de la proteasa en los pacientes con infecci\u00e3\u00b3n por el VIH","volume":"111","author":"Knobel","year":"1998","journal-title":"Med Clin (Barc)"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy","volume":"127","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/0003-4819-127-10-199711150-00017","article-title":"New-onset diabetes mellitus associated with use of protease inhibitor","volume":"127","author":"Eastone","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1345\/aph.17324","article-title":"Exacerbated hyperglycemia associated with nelfinavir","volume":"32","author":"Paterson","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib14","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"189","article-title":"Effects of protease inhibitor use on hyperglycemia and hyperlipidemia: a five year analysis [abstract 643]","author":"Tsiodras","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib15","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"189","article-title":"Prevalence and risk factors for hyperglycemia, dyslipemia, and coronary disease among HIV-infected patients on initial protease inhibitor therapy [abstract 644]","author":"Lee","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib16","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"190","article-title":"High prevalence of impaired glucose tolerance prior to initiating protease inhibitor therapy [abstract 650]","author":"Glesby","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archinte.1995.00430060109019","article-title":"Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection","volume":"155","author":"Nasti","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-116-1-53","article-title":"Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia","volume":"116","author":"Henry","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.7326\/0003-4819-119-10-199311150-00017","article-title":"Didanosine-induced disorders of glucose intolerance","volume":"119","author":"Albrecht","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1074\/jbc.270.22.13285","article-title":"Stimulation of \u00e2Prohormone Thiol Protease\u00e2\u2122 (PTP) and [Met] encephalin by forskolin","volume":"270","author":"Tezapsidis","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199511233332104","article-title":"Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function","volume":"333","author":"O\u0149Rahilly","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy","volume":"127","author":"Visnegavwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib23","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1210\/endo.137.11.8895388","article-title":"Immunological identification and localization of yeast aspartic protease 3-like prohormone processing enzymes in mammalian brain and pituitary","volume":"137","author":"Cawlwey","year":"1996","journal-title":"Endocrinology"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib24","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/597649","article-title":"Hypertrophy of the breast in a patient treated with indinavir","volume":"25","author":"Harry","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with the use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u00e2Buffalo hump\u00e2\u2122 in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"i","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI113586","article-title":"Effects of nonesterified fatty acid availability on tissue specific glucose utilisation in rats in vivo","volume":"82","author":"Jenkins","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(05)60719-2","article-title":"Metabolic abnormalities and use of HIV-1 protease inhibitors","volume":"352","author":"Mart-\u00b4nez","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib32","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"194","article-title":"Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitors (PI) [abstract 672]","author":"Saint-Marc","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib33","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"194","article-title":"Effects of the PPAR-activator-troglitazone on protease inhibitor associated peripheral insulin resistance [abstract 673]","author":"Walli","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib34","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"193","article-title":"Reversibility of protease inhibitor (PI) lipodystrophy syndrome on stopping Pis or switching to nelfinavir [abstract 668]","author":"Carr","year":"1999"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib35","series-title":"XII World AIDS Conference","first-page":"70","article-title":"Reversal of hyperlipidaemia and lipodystrophy in patients switching therapy to nelfinavir [abstract 12287]","author":"Duncombe","year":"1998"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib36","first-page":"554","article-title":"Protease inhibitor-associated hyperglycemia. Results of switching from indinavir to nelfinavir.nelfinavir [abstract 32172]","author":"Dube","year":"1998","journal-title":"XII World AIDS Conference, Geneve. Switzerland: 12th World AIDS Conference"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib37","first-page":"797","article-title":"Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine","volume":"13","author":"Mart-\u00b4nez","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.1469-0691.2000.00083.x_bib38","series-title":"6th Conference on Retrovirus and Opportunistic Infections","first-page":"193","article-title":"Management of indinavir-associated metabolic changes by substitution with efavirenz in virologically controlled HIV+ persons. Nelfinavir [abstract 669]","author":"Moyle","year":"1999"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14649843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14649843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T02:58:40Z","timestamp":1555037920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14649843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S1198743X14649843"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2000.00083.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}